Hester Biosciences to Divest 43.81% Stake in Texas Lifesciences for Rs 92 Million
Published on: March 11, 2026, 11:18 a.m. | Source: scanx.trade
Hester Biosciences has agreed to sell its 43.81% stake in Texas Lifesciences Private Limited for Rs 92 million. The transaction will result in TLPL no longer being a subsidiary of Hester Biosciences once the deal is completed, marking a strategic exit from this business vertical.
